Acute heart failure and pulmonary oedema
EBM Guidelines
Jan 19, 2022 • Completely updated
Table of contents
- Essentials
- General remarks
- Assessment of clinical status
- Laboratory test and imaging studies evd
- Differential diagnosis
- Triggering and aggravating factors
- Causal treatment
- Starting treatment, and treatment of congestive heart failure
- Prognostically beneficial medication of systolic heart failure evd
- Management of diuretic resistance
- Monitoring on the ward
- Post-discharge instructions and follow-up care plan
- References
Extract
- In the acute phase of heart failure, treatment consists of oxygen therapy and CPAP therapy for respiratory insufficiency, as necessary, intravenous diuretics and vasodilatation with nitrates. Opioids can be used for symptomatic treatment but, due to their adverse effects, their routine use should be avoided.
- Symptoms and findings are mostly due to congestion, and the aim of the treatment should be to relieve it completely during the hospital stay. Effective diuretic medication forms the cornerstone of treatment.
- The correction of the underlying cause and aggravating factors is crucial for a favourable outcome.
- Prognostically beneficial medication of systolic heart failure should be optimized during the hospital stay.
Read full article of Acute heart failure and pulmonary oedema
Search terms
AHF, Acute cardiac failure, Acute heart failure, Airway Obstruction, Atrial Fibrillation, B-type natriuretic peptide, BNP, Blood Pressure, CPAP, Cardiac failure, Cardiology, Congestive heart failure, Continuous Positive Airway Pressure, Digoxin, Diuretics, Dyspnea, Dyspnoea, ECG, Furosemide, Heart Failure, Congestive, Heart failure, I50*, Internal medicine, J81, Morphine, Myocardial Infarction, Nitrates, Oxygen Inhalation Therapy, PEEP, Pulmonary Edema, Pulmonary diseases, Pulmonary oedema, Sedation, Tachycardia, Supraventricular, Ventilators, Mechanical, blood pressure, systolic, chest x-ray, levosimendan, living will, nitrate infusion, nitroprusside